Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing ...
The discovery opens up opportunities to study the therapeutic properties of ibogaine and related compounds. Ibogaine, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback